Close Menu

NEW YORK – The US Food and Drug Administration cleared in vitro diagnostic tests in December from Luminex, Microgenics, Sentinel Diagnostics, i-Sens, and others, according to the agency's website.

Austin, Texas-based tests and platforms developer Luminex got the nod for its NxTag Respiratory Pathogen Panel, a qualitative test run on the firm's Magpix instrument to simultaneously detect and identify nucleic acids from multiple respiratory viruses and bacteria.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.